BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Valproic acid
,
rs6983267
,
MYC
,
Ischemia
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RNA polymerase III type 2 promoter DNA binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Peritoneum
Cervix
Duodenum
Bronchus
Trigeminal ganglia
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Legionella infection
Infection due to Bacteroides
Obsessive-compulsive disorder
Infectious disease of lung
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Digitoxin
Graphene
Droperidol
hexadecylpyridinium bromide
manganese chloride
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR181A1
MIR181B1
CPEB1
HR
FUBP3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Effect of TIM-3 stimulation on IgE/antigen-activated mouse mast cells
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Livers from a non-alcoholic steatohepatitis model miRNA expression profile
Chronically inflammed, cirrhotic and cancerous liver expression profiles
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for RNA polymerase III type 2 promoter DNA binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ